Jane Street
AGRX

Jane Street’s Agile Therapeutics AGRX Stock Holding History

Jane Street’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-891
Closed -$10.1K – 10382
2022
Q4 		$10.1K Sell
891
-490
-35% -$5.7K ﹤0.01% 8763
2022
Q3 		$20K Sell
1,381
-466
-25% -$11.5K ﹤0.01% 9206
2022
Q2 		$108K Buy
+1,847
New +$268K ﹤0.01% 8598
2022
Q1 		– Sell
-38
Closed -$37K – 11341
2021
Q4 		$37K Buy
+38
New +$53.6K ﹤0.01% 9644
2021
Q3 		– Sell
-70
Closed -$187K – 11045
2021
Q2 		$187K Buy
70
+60
+600% +$198K ﹤0.01% 8886
2021
Q1 		$41K Buy
+10
New +$54.1K ﹤0.01% 8877
2020
Q3 		– Sell
-54
Closed -$302K – 8189
2020
Q2 		$302K Buy
54
+36
+200% +$187K ﹤0.01% 5822
2020
Q1 		$68K Buy
18
+12
+200% +$68.9K ﹤0.01% 5043
2019
Q4 		$28K Buy
+6
New +$21K ﹤0.01% 4943
2018
Q4 		– Sell
-8
Closed -$6K – 5959
2018
Q3 		$6K Buy
+8
New +$5.86K ﹤0.01% 5001

Other funds holding AGRX

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Jane Street's AGRX Position: Q1 2023 in Review

Jane Street sold out of Agile Therapeutics (AGRX) in Q1 2023, closing a stake of 891 shares — an estimated $10.1K sold.

Jane Street first reported a position in AGRX in Q3 2018 and held it in 10 quarters. The position peaked at $302K in Q2 2020. 22 funds tracked by Wall St. Rank hold AGRX as of Q1 2023.

  • Jane Street reported no remaining Agile Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 891 Agile Therapeutics shares in Q1 2023, an estimated $10.1K.
  • Jane Street first reported a position in Agile Therapeutics in Q3 2018 and held it in 10 quarters.
  • Jane Street's Agile Therapeutics position peaked at $302K in Q2 2020.
  • 22 funds tracked by Wall St. Rank held Agile Therapeutics as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.